Bronchodilator response of advanced lung function parameters depending on COPD severity Source: International Congress 2016 – Functional assessment of the airways Year: 2016
Effect of dual bronchodilation with indacaterol/glycopirronium on small airways resistance in patients with stable COPD Source: International Congress 2016 – Non-inflammatory COPD monitoring Year: 2016
Does an acute FEV1 response predict long-term improvements with bronchodilators in patients with COPD? Source: Eur Respir J 2001; 18: Suppl. 33, 486s Year: 2001
The effects of bronchodilators on regional lung sound distribution in patients with COPD Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation Year: 2013
Evaluation of the individual bronchodilator response in patients with severe COPD Source: Eur Respir J 2002; 20: Suppl. 38, 246s Year: 2002
Comparison of protective effect of bronchodilators in COPD Source: International Congress 2015 – Safety of and interactions between current treatments for asthma and COPD Year: 2015
The effect of different bronchodilator drugs on pulmonary function tests, exercise capacity and quality of life in patients with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 515s Year: 2005
Clinically important deteriorations in COPD as a measure of response to dual and mono bronchodilator therapy with and without inhaled corticosteroids Source: International Congress 2015 – New data on established treatments for COPD Year: 2015
Predictors of lung function deterioration in COPD Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016
The bronchodilator test in patients with chronic airway obstruction: the responsiveness of lung function parameters Source: International Congress 2018 – Respiratory physiology and measurements Year: 2018
The improvements of lung function tests after formoterol administration in COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 323s Year: 2004
Changes in lung function in patients with acute COPD exacerbations: spirometry vs. forced oscillations Source: Eur Respir J 2001; 18: Suppl. 33, 149s Year: 2001
Lung function changes over time following withdrawal of inhaled corticosteroids in patients with severe COPD Source: Eur Respir J 2016; 47: 651-654 Year: 2016
Assessment of lung volumes and capacities in bronchodilator reversibility changes of hyperinflation of COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016
QVA149 provides superior peak lung function in patients with COPD Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings Year: 2013
Using different pulmonary function parameters for establising reversibility in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 808s Year: 2006
Lung function values as predictors for outcome during non-invasive ventilation in COPD patients Source: Annual Congress 2011 - New evidence in home mechanical ventilation Year: 2011
How the bronchodilatator in COPD patients works Source: Eur Respir J 2004; 24: Suppl. 48, 288s Year: 2004
Relevant and redundant lung function parameters in discriminating asthma from COPD Source: Eur Respir J 2005; 26: Suppl. 49, 362s Year: 2005
Effect of inhaled steroids on long term prognosis of lung function in adults with asthma Source: Eur Respir J 2004; 24: Suppl. 48, 664s Year: 2004